ADAykut Demirci

Aykut Demirci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aykut Demirci has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Halil Başar

    Department of Urology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey

    8 shared publications
  • Fatih Hızlı

    University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara Turkey

    5 shared publications
  • Halil Başar

    Department of Urology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey

    4 shared publications
  • Hayriye Dilek Hamurcu

    Department of Psychiatry, Dr. Abdurrahman Yurtaslan Oncology Research And Training Hospital, University of Health Sciences, Ankara, Türkiye

    3 shared publications
  • Tuncel Uzel

    University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Urology, Ankara, Turkey

    3 shared publications
  • Abdullah Bolat

    Department of Urology Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara Turkey

    2 shared publications

Latest Publications

  • Comparative Analysis of Oncological Outcomes between Trimodal Therapy and Radical Cystectomy in Patients with Variant Bladder Cancer

    by Aykut Demirci, Tuncel Uzel

    The aim of this study was to assess whether trimodal therapy (TMT) and radical cystectomy (RC) differ in terms of progression and survival outcomes in bladder cancer patients with variant histology (VH). A total of 57 patients diagnosed with VH, treated by either RC or TMT at our clinic between January 2013 and June 2024, were evaluated in this study. Group 1 (n = 44) included patients treated with TMT, while Group 2 (n = 13) consisted of those who underwent RC. The mean age of the patients was 64.43 ± 11.1 years. No statistically significant differences were observed between Group 1 and Group 2 in terms of PFS (p = 0.24), CSS (p = 0.07), or OS (p = 0.85). Patients with clinical stage < T2 demonstrated significantly improved PFS, OS, and CSS outcomes compared to those with stage ≥ T2 (p = 0.006, p = 0.006, and p = 0.001, respectively). Multivariable analysis identified T stage as an independent risk factor for PFS, CSS, and OS, irrespective of age, treatment modality, and VH type (HR: 5.45, p = 0.01; HR: 3.67, p = 0.006; and HR: 2.68, p = 0.01, respectively). While tumor stage remains a key prognostic factor in VH, our findings suggest that TMT may be a viable alternative to RC.

  • The Mediterranean Diet and Benign Prostatic Hyperplasia: A Pathway to Improved Urinary Health

    by İsa Dağlı, Tuncel Uzel, Muhammed Zübeyr Canbolat, Aykut Demirci, Fatih Hızlı

    Background: Lower urinary tract symptoms (LUTS) are highly prevalent among aging men and are often associated with benign prostatic hyperplasia (BPH), significantly impacting quality of life. The Mediterranean Diet (MedDiet), known for its anti‐inflammatory and antioxidant properties, has been hypothesized to alleviate LUTS and improve urological health.Objective: This study aimed to evaluate the impact of adherence to the MedDiet on uroflowmetry (UFM) parameters and International Prostate Symptom Scores (IPSS) in patients presenting with LUTS.Methods: A prospective study was conducted including 400 patients divided into two groups: MedDiet adherent (AMD, n = 193) and non‐adherent (NAMD, n = 207). Adherence was assessed using the Mediterranean Diet Adherence Screener (MEDAS). UFM parameters, post‐void residual (PVR) volumes, and IPSS were recorded. Statistical analyses were performed to evaluate group differences and correlations.Results: AMD patients exhibited significantly higher Qmax (13.87 ± 0.21 vs. 12.08 ± 0.19, p < 0.001) and lower IPSS (median: 9 vs. 17, p < 0.001) compared to the NAMD group. No significant differences were observed in Qaverage, PVR, or body mass index (BMI) between groups. Positive correlations were noted between MEDAS scores and Qmax (r = 0.259, p < 0.001), while IPSS showed a strong negative correlation with MEDAS scores (r = −0.610, p < 0.001).Conclusion: Adherence to the MedDiet may be associated with improved urinary function and reduced LUTS severity in BPH patients. These findings suggest the potential of dietary interventions as part of a holistic approach to managing BPH.


  • Open Access

    Do the ınflammatory markers have a prognostic role in an elderly patient population diagnosed with non-muscle ınvasive bladder cancer?

    by Aykut Demirci, Tuncel Uzel, Abdullah Bolat, Halil Baóar

    Objective: To evaluate whether the systemic immune-inflammation index (SII), neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), ...


  • Open Access

    Etiology of Hematospermia in Turkish Men: Multicentric Study

    by Serkan Gönültaş, Numan Baydilli, Mehmet Solakhan, Ahmet Güzel, Sina Kardaş, Aykut Demirci, Suhejb Sulejman, Serhat Yentür, Kemal Ertaş, Mustafa Gökhan Köse, et al.

    Hematospermia is defined as the presence of blood in the semen. The data regarding its etiology and management is variable across the literature. To investigate the etiology of hematospermia in Türkiye so as to contribute to the current management strategies for hematospermia. An online study protocol was published through the Turkish Urology Association communication network, and the centers that met the criteria were included in the study. All patients who presented with hematospermia complaints in the past 1 year were subjected to detailed anamnesis, physical examination, and routine laboratory tests. Based on the results, the patients were assigned to Group 1 (patients aged < 40 years with only one episode of hematospermia in the past 6 months) or Group 2 (patients with concomitant symptoms or ≥ 40 years or ≥ 2 times in the past 6 months). Radiological imaging was performed for the patients in Group 2. A total of 199 patients (Group 1: 44, Group 2: 155; mean age: 43.07 ± 14.73 years; age range: 16-73 years) from across 42 cities and 22 different centers were enrolled in this study. In the etiological classification, inflammation was identified as the most common cause (n = 76, 38.1%). Idiopathic hematospermia was higher in Group 1 than in Group 2 (70.4% vs. 112.2%, respectively), and hematospermia was associated with malignancy in 9 (5.8%) Group 2 patients. Positivity was detected in urine or semen cultures in 20 (12.9%) patients, and hematospermia occurred after COVID-19 infection in 2 patients. A significant correlation was noted between patients showing no-concomitant symptoms and those showing idiopathic hematospermia, inflammation, malignancy, varicocele, and multiple etiological factors (p = 0.004, p = 0.028, p = 0.002, p = 0.001, p = 0.026, p = 0.016). The most common radiological findings were an increase in the prostate volume (n = 48, 30.9%) and changes in the signal intensities of the seminal vesicles (n = 29, 18.7%). Despite the use of different approaches to manage idiopathic hematospermia, the patients' survey results were generally similar. Hematospermia in all age groups occurs generally due to self-limiting benign causes. Diagnostic imaging should therefore evaluate the elucidate etiology in patients with identified risk factors so as to avoid unnecessary treatments in idiopathic patients.

  • Open Access

    ¿Tienen los marcadores inflamatorios un papel pronóstico en una población de pacientes ancianos diagnosticados con cáncer de vejiga no invasivo?

    by Aykut Demirci, Tuncel Uzel, Abdullah Bolat, Halil Baóar

    Objetivo: El objetivo de este estudio fue evaluar si el índice de inmunoinflamación sistémica (SII), la relación neutrófil...


  • The effect of different adipose tissue measurements on clinical prognosis in bladder cancer patients undergoing radical cystectomy: preliminary results

    by Aykut Demirci, Hasan Aydın

    Purpose Obesity has been linked to an increased incidence of various cancers, including bladder cancer. Among the different types of adipose tissue, visceral fat is recognized as the most metabolically active. However, there is a notable scarcity of studies investigating the impact of fat distribution, as measured by computed tomography (CT), on the prognosis of bladder cancer patients undergoing radical cystectomy (RC). Materials and methods Between January 2013 and January 2024, preoperative CT images of 34 patients who underwent RC were analyzed to measure total perivesical fat area (TPFA, mm²), fat density (FD, %), and subcutaneous fat thickness (SFT, mm). Multivariate Cox regression analysis was used to assess the effects of these variables on prognosis. Results The median age (IQR) of the patients was 65.5 years (12.5), and the median BMI (IQR) was 26.05 (5.98) kg/m². The median follow-up period (IQR) was 11 (31.2) months. A positive correlation was observed between BMI, TPFA, and SFT (r = 0.39, p = 0.02; r = 0.69, p < 0.001, respectively). According to Cox regression analysis, SFT, T stage, and N stage were found to be predictive factors for progression (HR = 1.11, p = 0.007; HR = 4.01, p = 0.04; HR = 6.47, p = 0.02, respectively), and T stage was also identified as an independent predictor for overall survival (HR = 5.32, p = 0.04). Conclusion SFT measurement alongside clinical staging would be beneficial in determining progression following RC. Future randomized controlled trials supporting our findings will highlight the significance of these measurements. Graphical abstract

  • Open Access

    Can serum tumor marker densities according to tumor volume and testicle size be used to predict progression in patients with testicular cancer?

    by Aykut Demirci, Halil Başar

    Background: The objective of this study is to determine the role of tumor marker density (TMD) values such as alpha-fetoprotein tumor volume ratio (ATVR), beta-human chorionic gonadotropin tumor volume ratio (βTVR), alpha-fetoprotein testicle size ratio (ATSR), beta-human chorionic gonadotropin testicle size ratio (βTSR), lactate dehydrogenase tumor volume ratio (LTVR), and lactate dehydrogenase testicle size ratio (LTSR) in the determination of progression-free survival (PFS) in patients with testicular cancer. Materials and methods: A retrospective study was conducted of 95 patients followed-up in our clinic with a diagnosis of testicular cancer between January 2015 and August 2022. Patients were grouped according to clinical stage, as either early stage (n = 50) or advanced stage (n = 45). Clinical and pathological data and TMD values for all patients were recorded. Results: The median age of patients was 35 years (21–63 years). All TMDs except LTVR in advanced stage patients were found to be significantly higher than those of early stage patients (p < 0.05). Median ATVR (2.58 vs. 0.0), ATSR (0.63 vs. 0.03), βTVR (0.9 vs. 0.009), and βTSR (0.18 vs. 0.007) of the nonseminoma patients were found to be significantly higher than those of the seminoma patients, respectively (p < 0.001). Progression-free survival (months) was decreased in seminoma patients with high values of βTVR (11.3 ± 1.9 vs. 35.2 ± 0.7), βTSR (16.2 ± 3.4 vs. 35.2 ± 0.75), LTVR (17.7 ± 3.4 vs. 35.2 ± 0.7), and LTSR (21.5 ± 3.13 vs. 35.09 ± 0.8) (p < 0.001). Decreased PFS (months) was associated with higher values of ATVR (5.37 ± 0.7 vs. 35.05 ± 0.93), βTVR (7.4 ± 1.5 vs. 34.6 ± 1.3), ATSR (5.37 ± 0.75 vs. 35.05 ± 0.9), βTSR (7 ± 1.5 vs. 34.6 ± 1.3), and LTSR (7.9 ± 1.2 vs. 34.3 ± 1.5) in nonseminoma patients (p < 0.001). Based on multivariate analysis, βTVR-LTVR and ATVR-ATSR were determined to be independent risk factors for reduced PFS in seminoma and nonseminoma patients, respectively (p < 0.05). Conclusions: The results of this study suggest that the calculation of TMDs could be a promising and simple method for prediction of PFS among testicular cancer patients.